MINI FUTURE SHORT - AMGEN | Market Closed - Deutsche Boerse AG 01:20:34 18/05/2024 am IST | ||
| 9.59 EUR | +3.01% |
|
| Current month | -28.38% | ||
| 1 month | -33.31% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 17/24/17 | 9.59 | +3.01% |
| 16/24/16 | 9.31 | +2.20% |
| 15/24/15 | 9.11 | -7.70% |
| 14/24/14 | 9.87 | -3.71% |
| 13/24/13 | 10.25 | +2.40% |
Delayed Quote Deutsche Boerse AG
Last update May 18, 2024 at 01:20 am IST
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | AMGEN INC. |
| Issuer | 
BNP Paribas
|
| WKN | PN9W5B |
| ISIN | DE000PN9W5B7 |
| Date issued | 18/10/2023 |
| Strike | 416.6 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 12.68 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 16.01 € |
|---|---|
| Lowest since issue | 8.61 € |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
312.5
USD
Average target price
314.1
USD
Spread / Average Target
+0.51%
- Stock Market
- Certificates
- Certificat